Several more drugs with new immunological targets such as IL-12/23, IL-17, IL-23, IL-36, C5a, CD-20, CD-40, LTA4, and CXCR1/2 are presently under investigation for the treatment of acne inversa. The gene discussed is CD40; the disease is hidradenitis suppurativa.